Luigi Mangione's federal trial in connection with the death of UnitedHealthcare executive Brian Thompson will not begin until January 2027, a federal judge announced Monday, clearing the calendar to avoid conflicts with his state-level proceedings.
Manhattan federal court judge Margaret Garnett had previously considered holding the federal trial in November, but abandoned that timeline after recognizing that Mangione and his defense team would be tied up with his state case, which is scheduled to start in September. Jury selection in the federal proceedings will now begin January 5, 2027, with opening statements set for January 25, 2027. The trial is expected to last two to three weeks.
"As you know, I had hoped with perhaps undue optimism to preserve a possibility of a fall trial in this case," Garnett said during Monday's brief proceeding. "I'm going to adjourn the trial to our previously agreed backup date."
Mangione faces murder and weapons charges in his state case for the December 4, 2024 killing of Thompson on a Manhattan street. The federal case includes stalking counts. He has pleaded not guilty in both matters.
During Monday's appearance, which lasted roughly 20 minutes, Mangione was delayed by elevator problems at the courthouse, according to sources. He arrived in khaki jail scrubs and appeared attentive throughout the proceeding. His lead attorney, Karen Friedman Agnifilo, declined to comment on the case when approached by reporters.
The scheduling decision comes as Mangione's state case has become increasingly complicated. In mid-June, the defense team signaled plans to pursue an extreme emotional disturbance defense, a psychiatric strategy that would essentially require Mangione to admit to the killing while arguing he was not mentally responsible at the time of the crime. The move prompted Judge Gregory Carro to order the defense to disclose what mental condition Mangione allegedly suffered during the shooting.
However, shortly after that psychiatric defense strategy became public, Mangione's attorneys filed notice withdrawing the extreme emotional disturbance claim, leading Carro to maintain his sealing order on the June 3 conference where the strategy was first discussed. The withdrawal does not necessarily foreclose the defense from raising mental health arguments at trial, legal experts noted. The defense could still attempt to demonstrate severe emotional distress through testimony or evidence presented by prosecutors, potentially in hopes of securing a manslaughter conviction rather than a murder conviction.
Thompson's death sparked widespread national attention to healthcare industry frustrations and created a unusual public sympathy dynamic around Mangione, with some supporters adopting the label "Mangionistas."
Author James Rodriguez: "The drawn-out timeline here serves both sides, but it leaves plenty of room for the defense strategy to continue shifting as the state trial approaches."
Comments